+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Enteric Disease Testing Market By Product Type, By Technique, By Disease Type, By End User: Global Opportunity Analysis and Industry Forecast, 2023-2032

  • PDF Icon

    Report

  • 474 Pages
  • April 2023
  • Region: Global
  • Allied Market Research
  • ID: 3773044
Description Jump to:
The enteric disease testing market was valued at $3.87 Billion in 2022 and is estimated to reach $5.32 Billion by 2032, exhibiting a CAGR of 3.3% from 2023 to 2032. Enteric diseases are infections caused by various microorganisms, including bacteria, viruses, and parasites, that affect the gastrointestinal tract (also known as the enteric or digestive system). These diseases are typically spread through contaminated food or water, poor sanitation, or inadequate hygiene practices. Enteric diseases are tested using molecular diagnostics techniques and immunodiagnostic techniques. Testing for enteric diseases is important for treatment, and prevention of the spread of infectious diseases. Various reagents, consumables, and equipment are used in the testing of enteric diseases.

Major factors driving the growth of the enteric disease testing market include rise in technological advancement in testing reagents and equipment of enteric disease, increase in initiative taken by governments in developing countries to reduce the burden of infectious enteric diseases, peptic ulcer and surge in prevalence of enteric diseases such as E. coli infection, amoebiasis, giardiasis, H. pylori infection, shigella and salmonella infection. For instance, according to Centers for Disease Control and Prevention (CDC) 2023, campylobacter infection affects 1.5 million U.S. residents every year.

However, the high cost of equipment and high cost associated with molecular diagnostic assay are expected to hamper the enteric disease testing market growth. On the contrary, unmet medical demands in developing countries and lucrative opportunities in emerging economies are expected to create immense opportunities for enteric disease testing product manufacturers in the future.

Furthermore, the healthcare business is projected to witness growth, owing to a rise in the use of enteric disease testing for research and development activities, high demand for enteric disease testing kits, and high incidence rate of enteric diseases. In addition, rise in discovery & development of effective enteric disease testing kits & equipment and increase in awareness regarding diagnosis of enteric disease drive the growth of the enteric disease testing market in developing countries such as India and China. This is anticipated to offer remunerative opportunities for key players to invest in the market during the forecast period.

The enteric disease testing market is segmented into product type, technique, disease type, end user, and region. On the basis of product type, the market is classified into reagents and consumables, and equipment. On the basis of technique, the market is bifurcated into molecular diagnostics, and immunodiagnostics. On the basis of disease type, the market is divided into bacterial enteric disease, viral enteric disease, and parasitic enteric disease. On the basis of end user, it is segregated into hospital laboratories, pharmaceutical and biotechnology companies, academic and research institutes.

Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major players profiled in the report include Abbott Laboratories, Becton Dickinson & Company, Biomerica, Inc., Biomerieux SA, Bio-Rad Laboratories, Inc., Coris Bioconcept, Diasorin S.p.A., Meridian Bioscience, Inc, Quest Diagnostics, and Trinity Biotech.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the enteric disease testing market analysis from 2022 to 2032 to identify the prevailing enteric disease testing market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the enteric disease testing market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global enteric disease testing market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product Type

  • Reagents and Consumables
  • Equipment

By Technique

  • Molecular Diagnostics
  • Immunodiagnostics

By Disease Type

  • Bacterial Enteric Disease
  • Viral Enteric Disease
  • Parasitic Enteric Disease

By End User

  • Academic and Research Institutes
  • Hospital Laboratories
  • Pharmaceutical and Biotechnology Companies

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players

  • Biomerica, Inc.
  • Diasorin S.p.A.
  • Meridian Bioscience Inc.
  • Coris BioConcept
  • Abbott Laboratories
  • Biomerieux SA
  • Bio-Rad Laboratories, Inc.
  • Quest Diagnostics Inc.
  • Becton Dickinson & Company
  • Trinity Biotech

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in prevalence of enteric diseases
3.4.1.2. Untapped market in developing countries
3.4.2. Restraints
3.4.2.1. High cost associated with molecular diagnostic assay
3.4.3. Opportunities
3.4.3.1. Rise in adoption of developmental strategies by key players
3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Reagents and Consumables
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Equipment
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
CHAPTER 5: ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE
5.1. Overview
5.1.1. Market size and forecast
5.2. Molecular Diagnostics
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Immunodiagnostics
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
CHAPTER 6: ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE
6.1. Overview
6.1.1. Market size and forecast
6.2. Bacterial Enteric Disease
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Viral Enteric Disease
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Parasitic Enteric Disease
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: ENTERIC DISEASE TESTING MARKET, BY END USER
7.1. Overview
7.1.1. Market size and forecast
7.2. Hospital Laboratories
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by region
7.2.3. Market share analysis by country
7.3. Pharmaceutical and Biotechnology Companies
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by region
7.3.3. Market share analysis by country
7.4. Academic and Research Institutes
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by region
7.4.3. Market share analysis by country
CHAPTER 8: ENTERIC DISEASE TESTING MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast By Region
8.2. North America
8.2.1. Key trends and opportunities
8.2.2. Market size and forecast, by Product Type
8.2.3. Market size and forecast, by Technique
8.2.4. Market size and forecast, by Disease Type
8.2.5. Market size and forecast, by End User
8.2.6. Market size and forecast, by country
8.2.6.1. U.S.
8.2.6.1.1. Key market trends, growth factors and opportunities
8.2.6.1.2. Market size and forecast, by Product Type
8.2.6.1.3. Market size and forecast, by Technique
8.2.6.1.4. Market size and forecast, by Disease Type
8.2.6.1.5. Market size and forecast, by End User
8.2.6.2. Canada
8.2.6.2.1. Key market trends, growth factors and opportunities
8.2.6.2.2. Market size and forecast, by Product Type
8.2.6.2.3. Market size and forecast, by Technique
8.2.6.2.4. Market size and forecast, by Disease Type
8.2.6.2.5. Market size and forecast, by End User
8.2.6.3. Mexico
8.2.6.3.1. Key market trends, growth factors and opportunities
8.2.6.3.2. Market size and forecast, by Product Type
8.2.6.3.3. Market size and forecast, by Technique
8.2.6.3.4. Market size and forecast, by Disease Type
8.2.6.3.5. Market size and forecast, by End User
8.3. Europe
8.3.1. Key trends and opportunities
8.3.2. Market size and forecast, by Product Type
8.3.3. Market size and forecast, by Technique
8.3.4. Market size and forecast, by Disease Type
8.3.5. Market size and forecast, by End User
8.3.6. Market size and forecast, by country
8.3.6.1. Germany
8.3.6.1.1. Key market trends, growth factors and opportunities
8.3.6.1.2. Market size and forecast, by Product Type
8.3.6.1.3. Market size and forecast, by Technique
8.3.6.1.4. Market size and forecast, by Disease Type
8.3.6.1.5. Market size and forecast, by End User
8.3.6.2. France
8.3.6.2.1. Key market trends, growth factors and opportunities
8.3.6.2.2. Market size and forecast, by Product Type
8.3.6.2.3. Market size and forecast, by Technique
8.3.6.2.4. Market size and forecast, by Disease Type
8.3.6.2.5. Market size and forecast, by End User
8.3.6.3. UK
8.3.6.3.1. Key market trends, growth factors and opportunities
8.3.6.3.2. Market size and forecast, by Product Type
8.3.6.3.3. Market size and forecast, by Technique
8.3.6.3.4. Market size and forecast, by Disease Type
8.3.6.3.5. Market size and forecast, by End User
8.3.6.4. Italy
8.3.6.4.1. Key market trends, growth factors and opportunities
8.3.6.4.2. Market size and forecast, by Product Type
8.3.6.4.3. Market size and forecast, by Technique
8.3.6.4.4. Market size and forecast, by Disease Type
8.3.6.4.5. Market size and forecast, by End User
8.3.6.5. Spain
8.3.6.5.1. Key market trends, growth factors and opportunities
8.3.6.5.2. Market size and forecast, by Product Type
8.3.6.5.3. Market size and forecast, by Technique
8.3.6.5.4. Market size and forecast, by Disease Type
8.3.6.5.5. Market size and forecast, by End User
8.3.6.6. Rest of Europe
8.3.6.6.1. Key market trends, growth factors and opportunities
8.3.6.6.2. Market size and forecast, by Product Type
8.3.6.6.3. Market size and forecast, by Technique
8.3.6.6.4. Market size and forecast, by Disease Type
8.3.6.6.5. Market size and forecast, by End User
8.4. Asia-Pacific
8.4.1. Key trends and opportunities
8.4.2. Market size and forecast, by Product Type
8.4.3. Market size and forecast, by Technique
8.4.4. Market size and forecast, by Disease Type
8.4.5. Market size and forecast, by End User
8.4.6. Market size and forecast, by country
8.4.6.1. Japan
8.4.6.1.1. Key market trends, growth factors and opportunities
8.4.6.1.2. Market size and forecast, by Product Type
8.4.6.1.3. Market size and forecast, by Technique
8.4.6.1.4. Market size and forecast, by Disease Type
8.4.6.1.5. Market size and forecast, by End User
8.4.6.2. China
8.4.6.2.1. Key market trends, growth factors and opportunities
8.4.6.2.2. Market size and forecast, by Product Type
8.4.6.2.3. Market size and forecast, by Technique
8.4.6.2.4. Market size and forecast, by Disease Type
8.4.6.2.5. Market size and forecast, by End User
8.4.6.3. Australia
8.4.6.3.1. Key market trends, growth factors and opportunities
8.4.6.3.2. Market size and forecast, by Product Type
8.4.6.3.3. Market size and forecast, by Technique
8.4.6.3.4. Market size and forecast, by Disease Type
8.4.6.3.5. Market size and forecast, by End User
8.4.6.4. India
8.4.6.4.1. Key market trends, growth factors and opportunities
8.4.6.4.2. Market size and forecast, by Product Type
8.4.6.4.3. Market size and forecast, by Technique
8.4.6.4.4. Market size and forecast, by Disease Type
8.4.6.4.5. Market size and forecast, by End User
8.4.6.5. South Korea
8.4.6.5.1. Key market trends, growth factors and opportunities
8.4.6.5.2. Market size and forecast, by Product Type
8.4.6.5.3. Market size and forecast, by Technique
8.4.6.5.4. Market size and forecast, by Disease Type
8.4.6.5.5. Market size and forecast, by End User
8.4.6.6. Rest of Asia-Pacific
8.4.6.6.1. Key market trends, growth factors and opportunities
8.4.6.6.2. Market size and forecast, by Product Type
8.4.6.6.3. Market size and forecast, by Technique
8.4.6.6.4. Market size and forecast, by Disease Type
8.4.6.6.5. Market size and forecast, by End User
8.5. LAMEA
8.5.1. Key trends and opportunities
8.5.2. Market size and forecast, by Product Type
8.5.3. Market size and forecast, by Technique
8.5.4. Market size and forecast, by Disease Type
8.5.5. Market size and forecast, by End User
8.5.6. Market size and forecast, by country
8.5.6.1. Brazil
8.5.6.1.1. Key market trends, growth factors and opportunities
8.5.6.1.2. Market size and forecast, by Product Type
8.5.6.1.3. Market size and forecast, by Technique
8.5.6.1.4. Market size and forecast, by Disease Type
8.5.6.1.5. Market size and forecast, by End User
8.5.6.2. Saudi Arabia
8.5.6.2.1. Key market trends, growth factors and opportunities
8.5.6.2.2. Market size and forecast, by Product Type
8.5.6.2.3. Market size and forecast, by Technique
8.5.6.2.4. Market size and forecast, by Disease Type
8.5.6.2.5. Market size and forecast, by End User
8.5.6.3. South Africa
8.5.6.3.1. Key market trends, growth factors and opportunities
8.5.6.3.2. Market size and forecast, by Product Type
8.5.6.3.3. Market size and forecast, by Technique
8.5.6.3.4. Market size and forecast, by Disease Type
8.5.6.3.5. Market size and forecast, by End User
8.5.6.4. Rest of LAMEA
8.5.6.4.1. Key market trends, growth factors and opportunities
8.5.6.4.2. Market size and forecast, by Product Type
8.5.6.4.3. Market size and forecast, by Technique
8.5.6.4.4. Market size and forecast, by Disease Type
8.5.6.4.5. Market size and forecast, by End User
CHAPTER 9: COMPETITIVE LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Top player positioning, 2022
CHAPTER 10: COMPANY PROFILES
10.1. Becton Dickinson & Company
10.1.1. Company overview
10.1.2. Key Executives
10.1.3. Company snapshot
10.1.4. Operating business segments
10.1.5. Product portfolio
10.1.6. Business performance
10.2. Biomerica, Inc.
10.2.1. Company overview
10.2.2. Key Executives
10.2.3. Company snapshot
10.2.4. Operating business segments
10.2.5. Product portfolio
10.2.6. Business performance
10.3. Biomerieux SA
10.3.1. Company overview
10.3.2. Key Executives
10.3.3. Company snapshot
10.3.4. Operating business segments
10.3.5. Product portfolio
10.3.6. Business performance
10.3.7. Key strategic moves and developments
10.4. Bio-Rad Laboratories, Inc.
10.4.1. Company overview
10.4.2. Key Executives
10.4.3. Company snapshot
10.4.4. Operating business segments
10.4.5. Product portfolio
10.4.6. Business performance
10.5. Diasorin S.p.A.
10.5.1. Company overview
10.5.2. Key Executives
10.5.3. Company snapshot
10.5.4. Operating business segments
10.5.5. Product portfolio
10.5.6. Business performance
10.5.7. Key strategic moves and developments
10.6. Meridian Bioscience Inc.
10.6.1. Company overview
10.6.2. Key Executives
10.6.3. Company snapshot
10.6.4. Operating business segments
10.6.5. Product portfolio
10.6.6. Business performance
10.6.7. Key strategic moves and developments
10.7. Quest Diagnostics Inc.
10.7.1. Company overview
10.7.2. Key Executives
10.7.3. Company snapshot
10.7.4. Operating business segments
10.7.5. Product portfolio
10.7.6. Business performance
10.7.7. Key strategic moves and developments
10.8. Trinity Biotech
10.8.1. Company overview
10.8.2. Key Executives
10.8.3. Company snapshot
10.8.4. Operating business segments
10.8.5. Product portfolio
10.8.6. Business performance
10.8.7. Key strategic moves and developments
10.9. Coris BioConcept
10.9.1. Company overview
10.9.2. Key Executives
10.9.3. Company snapshot
10.9.4. Operating business segments
10.9.5. Product portfolio
10.10. Abbott Laboratories
10.10.1. Company overview
10.10.2. Key Executives
10.10.3. Company snapshot
10.10.4. Operating business segments
10.10.5. Product portfolio
10.10.6. Business performance
List of Tables
TABLE 01. GLOBAL ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 02. ENTERIC DISEASE TESTING MARKET FOR REAGENTS AND CONSUMABLES, BY REGION, 2022-2032 ($MILLION)
TABLE 03. ENTERIC DISEASE TESTING MARKET FOR EQUIPMENT, BY REGION, 2022-2032 ($MILLION)
TABLE 04. GLOBAL ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 05. ENTERIC DISEASE TESTING MARKET FOR MOLECULAR DIAGNOSTICS, BY REGION, 2022-2032 ($MILLION)
TABLE 06. ENTERIC DISEASE TESTING MARKET FOR IMMUNODIAGNOSTICS, BY REGION, 2022-2032 ($MILLION)
TABLE 07. GLOBAL ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 08. ENTERIC DISEASE TESTING MARKET FOR BACTERIAL ENTERIC DISEASE, BY REGION, 2022-2032 ($MILLION)
TABLE 09. ENTERIC DISEASE TESTING MARKET FOR VIRAL ENTERIC DISEASE, BY REGION, 2022-2032 ($MILLION)
TABLE 10. ENTERIC DISEASE TESTING MARKET FOR PARASITIC ENTERIC DISEASE, BY REGION, 2022-2032 ($MILLION)
TABLE 11. GLOBAL ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 12. ENTERIC DISEASE TESTING MARKET FOR HOSPITAL LABORATORIES, BY REGION, 2022-2032 ($MILLION)
TABLE 13. ENTERIC DISEASE TESTING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2032 ($MILLION)
TABLE 14. ENTERIC DISEASE TESTING MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2022-2032 ($MILLION)
TABLE 15. ENTERIC DISEASE TESTING MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 16. NORTH AMERICA ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 17. NORTH AMERICA ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 18. NORTH AMERICA ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 19. NORTH AMERICA ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 20. NORTH AMERICA ENTERIC DISEASE TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 21. U.S. ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 22. U.S. ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 23. U.S. ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 24. U.S. ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 25. CANADA ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 26. CANADA ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 27. CANADA ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 28. CANADA ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 29. MEXICO ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 30. MEXICO ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 31. MEXICO ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 32. MEXICO ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 33. EUROPE ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 34. EUROPE ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 35. EUROPE ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 36. EUROPE ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 37. EUROPE ENTERIC DISEASE TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 38. GERMANY ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 39. GERMANY ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 40. GERMANY ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 41. GERMANY ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 42. FRANCE ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 43. FRANCE ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 44. FRANCE ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 45. FRANCE ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 46. UK ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 47. UK ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 48. UK ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 49. UK ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 50. ITALY ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 51. ITALY ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 52. ITALY ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 53. ITALY ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 54. SPAIN ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 55. SPAIN ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 56. SPAIN ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 57. SPAIN ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 58. REST OF EUROPE ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 59. REST OF EUROPE ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 60. REST OF EUROPE ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 61. REST OF EUROPE ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 62. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 63. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 64. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 65. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 66. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 67. JAPAN ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 68. JAPAN ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 69. JAPAN ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 70. JAPAN ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 71. CHINA ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 72. CHINA ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 73. CHINA ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 74. CHINA ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 75. AUSTRALIA ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 76. AUSTRALIA ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 77. AUSTRALIA ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 78. AUSTRALIA ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 79. INDIA ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 80. INDIA ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 81. INDIA ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 82. INDIA ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 83. SOUTH KOREA ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 84. SOUTH KOREA ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 85. SOUTH KOREA ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 86. SOUTH KOREA ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 87. REST OF ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 88. REST OF ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 89. REST OF ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 90. REST OF ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 91. LAMEA ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 92. LAMEA ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 93. LAMEA ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 94. LAMEA ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 95. LAMEA ENTERIC DISEASE TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 96. BRAZIL ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 97. BRAZIL ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 98. BRAZIL ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 99. BRAZIL ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 100. SAUDI ARABIA ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 101. SAUDI ARABIA ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 102. SAUDI ARABIA ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 103. SAUDI ARABIA ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 104. SOUTH AFRICA ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 105. SOUTH AFRICA ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 106. SOUTH AFRICA ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 107. SOUTH AFRICA ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 108. REST OF LAMEA ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 109. REST OF LAMEA ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 110. REST OF LAMEA ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 111. REST OF LAMEA ENTERIC DISEASE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 112. BECTON DICKINSON & COMPANY: KEY EXECUTIVES
TABLE 113. BECTON DICKINSON & COMPANY: COMPANY SNAPSHOT
TABLE 114. BECTON DICKINSON & COMPANY: PRODUCT SEGMENTS
TABLE 115. BECTON DICKINSON & COMPANY: PRODUCT PORTFOLIO
TABLE 116. BIOMERICA, INC.: KEY EXECUTIVES
TABLE 117. BIOMERICA, INC.: COMPANY SNAPSHOT
TABLE 118. BIOMERICA, INC.: PRODUCT SEGMENTS
TABLE 119. BIOMERICA, INC.: PRODUCT PORTFOLIO
TABLE 120. BIOMERIEUX SA: KEY EXECUTIVES
TABLE 121. BIOMERIEUX SA: COMPANY SNAPSHOT
TABLE 122. BIOMERIEUX SA: PRODUCT SEGMENTS
TABLE 123. BIOMERIEUX SA: PRODUCT PORTFOLIO
TABLE 124. BIOMERIEUX SA: KEY STRATEGIES
TABLE 125. BIO-RAD LABORATORIES, INC. : KEY EXECUTIVES
TABLE 126. BIO-RAD LABORATORIES, INC. : COMPANY SNAPSHOT
TABLE 127. BIO-RAD LABORATORIES, INC. : PRODUCT SEGMENTS
TABLE 128. BIO-RAD LABORATORIES, INC. : PRODUCT PORTFOLIO
TABLE 129. DIASORIN S.P.A.: KEY EXECUTIVES
TABLE 130. DIASORIN S.P.A.: COMPANY SNAPSHOT
TABLE 131. DIASORIN S.P.A.: PRODUCT SEGMENTS
TABLE 132. DIASORIN S.P.A.: PRODUCT PORTFOLIO
TABLE 133. DIASORIN S.P.A.: KEY STRATEGIES
TABLE 134. MERIDIAN BIOSCIENCE INC.: KEY EXECUTIVES
TABLE 135. MERIDIAN BIOSCIENCE INC.: COMPANY SNAPSHOT
TABLE 136. MERIDIAN BIOSCIENCE INC.: PRODUCT SEGMENTS
TABLE 137. MERIDIAN BIOSCIENCE INC.: PRODUCT PORTFOLIO
TABLE 138. MERIDIAN BIOSCIENCE INC.: KEY STRATEGIES
TABLE 139. QUEST DIAGNOSTICS INC.: KEY EXECUTIVES
TABLE 140. QUEST DIAGNOSTICS INC.: COMPANY SNAPSHOT
TABLE 141. QUEST DIAGNOSTICS INC.: SERVICE SEGMENTS
TABLE 142. QUEST DIAGNOSTICS INC.: PRODUCT PORTFOLIO
TABLE 143. QUEST DIAGNOSTICS INC.: KEY STRATEGIES
TABLE 144. TRINITY BIOTECH: KEY EXECUTIVES
TABLE 145. TRINITY BIOTECH: COMPANY SNAPSHOT
TABLE 146. TRINITY BIOTECH: PRODUCT SEGMENTS
TABLE 147. TRINITY BIOTECH: PRODUCT PORTFOLIO
TABLE 148. TRINITY BIOTECH: KEY STRATEGIES
TABLE 149. CORIS BIOCONCEPT: KEY EXECUTIVES
TABLE 150. CORIS BIOCONCEPT: COMPANY SNAPSHOT
TABLE 151. CORIS BIOCONCEPT: PRODUCT SEGMENTS
TABLE 152. CORIS BIOCONCEPT: PRODUCT PORTFOLIO
TABLE 153. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 154. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 155. ABBOTT LABORATORIES: PRODUCT SEGMENTS
TABLE 156. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
List of Figures
FIGURE 01. ENTERIC DISEASE TESTING MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF ENTERIC DISEASE TESTING MARKET, 2022-2032
FIGURE 03. TOP INVESTMENT POCKETS IN ENTERIC DISEASE TESTING MARKET (2023-2032)
FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS
FIGURE 05. LOW BARGAINING POWER OF BUYERS
FIGURE 06. LOW THREAT OF SUBSTITUTES
FIGURE 07. LOW THREAT OF NEW ENTRANTS
FIGURE 08. LOW INTENSITY OF RIVALRY
FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALENTERIC DISEASE TESTING MARKET
FIGURE 10. ENTERIC DISEASE TESTING MARKET, BY PRODUCT TYPE, 2022(%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF ENTERIC DISEASE TESTING MARKET FOR REAGENTS AND CONSUMABLES, BY COUNTRY 2022 AND 2032(%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF ENTERIC DISEASE TESTING MARKET FOR EQUIPMENT, BY COUNTRY 2022 AND 2032(%)
FIGURE 13. ENTERIC DISEASE TESTING MARKET, BY TECHNIQUE, 2022(%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF ENTERIC DISEASE TESTING MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY 2022 AND 2032(%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF ENTERIC DISEASE TESTING MARKET FOR IMMUNODIAGNOSTICS, BY COUNTRY 2022 AND 2032(%)
FIGURE 16. ENTERIC DISEASE TESTING MARKET, BY DISEASE TYPE, 2022(%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF ENTERIC DISEASE TESTING MARKET FOR BACTERIAL ENTERIC DISEASE, BY COUNTRY 2022 AND 2032(%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF ENTERIC DISEASE TESTING MARKET FOR VIRAL ENTERIC DISEASE, BY COUNTRY 2022 AND 2032(%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF ENTERIC DISEASE TESTING MARKET FOR PARASITIC ENTERIC DISEASE, BY COUNTRY 2022 AND 2032(%)
FIGURE 20. ENTERIC DISEASE TESTING MARKET, BY END USER, 2022(%)
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF ENTERIC DISEASE TESTING MARKET FOR HOSPITAL LABORATORIES, BY COUNTRY 2022 AND 2032(%)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF ENTERIC DISEASE TESTING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY 2022 AND 2032(%)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF ENTERIC DISEASE TESTING MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY 2022 AND 2032(%)
FIGURE 24. ENTERIC DISEASE TESTING MARKET BY REGION, 2022
FIGURE 25. U.S. ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 26. CANADA ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 27. MEXICO ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 28. GERMANY ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 29. FRANCE ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 30. UK ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 31. ITALY ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 32. SPAIN ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 33. REST OF EUROPE ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 34. JAPAN ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 35. CHINA ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 36. AUSTRALIA ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 37. INDIA ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 38. SOUTH KOREA ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 39. REST OF ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 40. BRAZIL ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 41. SAUDI ARABIA ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 42. SOUTH AFRICA ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 43. REST OF LAMEA ENTERIC DISEASE TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 44. TOP WINNING STRATEGIES, BY YEAR
FIGURE 45. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 46. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 47. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 48. COMPETITIVE DASHBOARD
FIGURE 49. COMPETITIVE HEATMAP: ENTERIC DISEASE TESTING MARKET
FIGURE 50. TOP PLAYER POSITIONING, 2022
FIGURE 51. BECTON DICKINSON & COMPANY: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 52. BECTON DICKINSON & COMPANY: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
FIGURE 53. BECTON DICKINSON & COMPANY: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 54. BECTON DICKINSON & COMPANY: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 55. BIOMERICA, INC.: NET REVENUE, 2019-2021 ($MILLION)
FIGURE 56. BIOMERICA, INC.: RESEARCH & DEVELOPMENT EXPENDITURE, 2019-2021 ($MILLION)
FIGURE 57. BIOMERICA, INC.: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 58. BIOMERIEUX SA: NET SALES, 2019-2021 ($MILLION)
FIGURE 59. BIOMERIEUX SA: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 60. BIOMERIEUX SA: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 61. BIO-RAD LABORATORIES, INC. : NET SALES, 2020-2022 ($MILLION)
FIGURE 62. BIO-RAD LABORATORIES, INC. : REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 63. BIO-RAD LABORATORIES, INC. : REVENUE SHARE BY REGION, 2022 (%)
FIGURE 64. DIASORIN S.P.A.: NET REVENUE, 2019-2021 ($MILLION)
FIGURE 65. DIASORIN S.P.A.: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 66. MERIDIAN BIOSCIENCE INC.: NET REVENUE, 2019-2021 ($MILLION)
FIGURE 67. MERIDIAN BIOSCIENCE INC.: RESEARCH & DEVELOPMENT EXPENDITURE, 2019-2021 ($MILLION)
FIGURE 68. MERIDIAN BIOSCIENCE INC.: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 69. MERIDIAN BIOSCIENCE INC.: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 70. QUEST DIAGNOSTICS INC.: NET REVENUE, 2019-2021 ($MILLION)
FIGURE 71. QUEST DIAGNOSTICS INC.: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 72. TRINITY BIOTECH: NET REVENUE, 2019-2021 ($MILLION)
FIGURE 73. TRINITY BIOTECH: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 74. TRINITY BIOTECH: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 75. ABBOTT LABORATORIES: NET SALES, 2020-2022 ($MILLION)
FIGURE 76. ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 77. ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2022 (%)

Companies Mentioned

  • Biomerica, Inc.
  • Diasorin S.p.A.
  • Meridian Bioscience Inc.
  • Coris BioConcept
  • Abbott Laboratories
  • Biomerieux SA
  • Bio-Rad Laboratories, Inc.
  • Quest Diagnostics Inc.
  • Becton Dickinson & Company
  • Trinity Biotech

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Related Topics

Related Reports

Global Enteric Disease Testing Market Report and Forecast 2024-2032 - Product Image

Global Enteric Disease Testing Market Report and Forecast 2024-2032

  • Report
  • 160 Pages
  • Global
From
Enteric Disease Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 - Product Image

Enteric Disease Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • Report
  • 145 Pages
  • Global
From
Enteric Disease Testing Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts - 2023 to 2031 - Product Image

Enteric Disease Testing Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts - 2023 to 2031

  • Report
  • 110 Pages
  • Global
From
Enteric Disease Testing Market Size, Share & Trends Analysis Report By Disease Type (Bacterial Enteric Diseases, Viral Enteric Diseases, Parasitic Enteric Diseases), By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Enteric Disease Testing Market Size, Share & Trends Analysis Report By Disease Type (Bacterial Enteric Diseases, Viral Enteric Diseases, Parasitic Enteric Diseases), By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 90 Pages
  • Global
From
Enteric Disease Testing Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030 - Product Image

Enteric Disease Testing Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030

  • Report
  • 146 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.